Pharmaceutical formulation
US11278506B2 · kind B2 · utility
1Cited by
116References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2016 |
| Grant date | Mar 22, 2022 |
| Priority date | — |
| Expiry date | Oct 11, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/485
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A formulation for oral administration comprises an expectorant, an analgesic, and at least one additional active ingredient having a modified release providing a therapeutic effect for each of the active ingredients for up to 12 hours.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.